Vault-13

COLLPLANT BIOTECHNOLOGIES LT

ADS · CUSIP 19516R107

2 institutional holders -14 vs Q1 2021
552,029552.0k shares reported held*
$11.7mreported value*
0 new 0 added 1 reduced 14 sold out net sold ≈ $26.7m (-1.3m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $21.21.

Trends to Q2 2021

Institutional holders

Managers reporting a position, each quarter

01020Q4 19: 2Q1 20: 4Q2 20: 7Q3 20: 8Q4 20: 7Q1 21: 16Q2 21: 22Q4 19Q2 20Q4 20Q2 21
Numbers
QuarterHolders
Q4 20192
Q1 20204
Q2 20207
Q3 20208
Q4 20207
Q1 202116
Q2 20212

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q1 20: 3 bought or addedQ1 20: 1 cut or sold outQ1 20Q2 20: 5 bought or addedQ2 20: 1 cut or sold outQ2 20Q3 20: 5 bought or addedQ3 20: 1 cut or sold outQ3 20Q4 20: 5 bought or addedQ4 20: 3 cut or sold outQ4 20Q1 21: 14 bought or addedQ1 21: 1 cut or sold outQ1 21Q2 21: 0 bought or addedQ2 21: 15 cut or sold outQ2 21
Numbers
QuarterBought or addedCut or sold out
Q1 202031
Q2 202051
Q3 202051
Q4 202053
Q1 2021141
Q2 2021015

Biggest buyers

None

Biggest sellers

INVESTMENT MANAGEMENT OF VIRGINIA LLC Sold out -530,400-530.4k
FRIESS ASSOCIATES LLC Sold out -250,091-250.1k
VILLERE ST DENIS J & CO LLC Sold out -242,250-242.2k
BENJAMIN F. EDWARDS & COMPANY, INC. Sold out -69,820-69.8k
BROWN ADVISORY INC Sold out -54,650-54.6k
Weil Company, Inc. Sold out -34,968-35.0k
RAYMOND JAMES & ASSOCIATES Sold out -20,800-20.8k
Sigma Planning Corp Sold out -19,700-19.7k
SABBY MANAGEMENT, LLC Sold out -17,045-17.0k
FNY Investment Advisers, LLC Sold out -10,000-10.0k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Loewenbaum Lilian S. 13D · may seek influence -7.5 pts · filed 2026-08-21
Stated purposeOn June 29, 2026, The Loewenbaum 1992 Trust entered into a Securities Purchase Agreement with the Issuer for the purchase of 1,764,706 Ordinary Shares, Series A Warrants to purchase 1,764,706 Ordinary Shares (the "Series A Warrants"), and Series B Warrants to purchase 3,529,412 Ordinary Shares (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The transaction was completed on July 6, 2026. The Series A Warrants have an exercise price of $0.34 per share and are exercisable as of July 29, 2026, the date of shareholder approval (the "Shareholder Approval Date"). The Series A Warrants expire on July 16, 2028. The Series B Warrants have an exercise price of $0.34 per share and are exercisable as of the Shareholder Approval Date. The Series B Warrants expire on… Full filing
17.5% -7.5 pts 3.6m 2026-08-21
Sagy Ami 13D · may seek influence filed 2025-11-28
Stated purposeThe Reporting Person is filing this Amendment No. 4 to Schedule 13D ("Amendment No. 4") to report his sale of 140,000 Ordinary Shares during the period from October 16, 2025 through November 19, 2025. Furthermore, since he last filed Amendment No. 3 to Schedule 13D on November 5, 2019, the Reporting Person's beneficial ownership has decreased materially. The Reporting Person holds the Ordinary Shares reported herein for investment purposes only. The Reporting Person may, from time to time, based on various factors, acquire additional Ordinary Shares of the Issuer or sell Ordinary Shares, on the open market or in privately negotiated transactions. Except as described above, as of the filing of this Amendment No. 4, the Reporting Person does not have any definitive plans or proposals which… Full filing
12.9% 1.6m 2025-11-28

Holders, Q2 2021

#ManagerLocationShares Value% of their portfolioChangeShares change
1 MEITAV INVESTMENT HOUSE LTD 0.15% of their portfolio BENE-BERAQ, L3 547,730547.7k $11.6m $11.6m 0.15% Unchanged
2 Parallel Advisors, LLC 0.00% of their portfolio SAN FRANCISCO, CA 4,2994.3k $91.0k $91.0k 0.00% Reduced -823 -823